Industrial R&D investment offers a useful view of where large companies are directing resources to develop products, processes and technologies. The 2018 EU Industrial R&D Investment Scoreboard examined 2,500 of the world’s largest corporate R&D investors, providing industrial automation engineers, system integrators and business leaders with a snapshot of investment patterns across regions and sectors.
The figures describe company accounts for the 2017/18 reporting period, rather than a forecast. They do not measure the full innovation activity of every business, but they do show how concentrated corporate R&D is and how differently major economies specialize. For decision-makers, that context can inform technology monitoring, supplier discussions and long-term planning.
Industrial R&D investment is highly concentrated
The 2,500 companies in the global sample each invested more than €25 million in R&D. Their combined investment reached €736.4 billion, approximately 90% of business-funded R&D worldwide, and increased 8.3% from the previous period. The report notes that exchange-rate movements affected the euro comparison: at the previous edition’s exchange rates, the total would have been about €800 billion.
Spending was concentrated among a relatively small group of firms. The top 10 companies accounted for 15% of the sample’s R&D, the top 50 for 40%, and the top 100 for 53%. Samsung was the largest investor at €13.44 billion, followed by Alphabet and Volkswagen. This concentration matters when interpreting industry trends: shifts in a small number of major companies can influence aggregate results.
Regional shares also differed. EU companies represented 27% of the total, US companies 37%, Japanese companies 14% and Chinese companies 10%. Over the decade reviewed, the EU share remained around 26–27%, while China’s share increased and Japan’s declined.
Sector mix shapes regional R&D profiles
The balance of investment varied substantially by region. In the EU, automotive accounted for 30.5% of R&D in the sample, health for 22.4% and ICT for 20.1%. The US profile was more heavily weighted toward ICT, at 51.4%, and health, at 26.7%; automotive represented 7.8%. Japan devoted 30.8% to automotive and 24.9% to ICT, while China’s profile included 44.7% in ICT, 11.4% in automotive and 3.4% in health.
These differences are relevant to industrial organizations because regional totals alone can hide sector specialization. An automation supplier evaluating potential markets, for example, may find it more informative to examine investment in the sectors it serves than to compare national R&D totals in isolation. The Scoreboard does not establish how much of this spending goes to factory automation specifically, but it can help identify where corporate R&D activity is concentrated.
Worldwide, ICT services recorded 13% R&D growth and ICT producers 11%, followed by health at 7.7%. Industrials grew 3.3%, while aerospace and defence declined 4.3%. Across the longer period, ICT services showed the strongest growth, followed by automotive and ICT producers.
R&D intensity reveals a different competitive picture
R&D intensity—the ratio of R&D spending to net sales—helps compare investment relative to company scale. It varies by sector: the Scoreboard identifies ICT and health as the highest-intensity areas, followed by medium-high-technology sectors such as automotive and engineering.
In the 2017/18 comparison, average intensity was 6.3% for US companies, 3.4% for both EU and Japanese companies, and 2.8% for Chinese companies. These averages reflect both the sectors in which companies operate and the intensity of investment within each sector. The report found that US companies had higher intensity in ICT and health, while EU companies had an increasing advantage in automotive. China’s faster R&D growth in ICT was narrowing the EU’s overall intensity advantage over Chinese companies.
For automation leaders, the distinction between sector mix and within-sector intensity is important. A region’s lower average may partly reflect a different industrial composition, rather than uniformly lower investment across every field. Likewise, a strong automotive R&D profile should not be assumed to indicate equivalent strength in software or health technologies.
What the findings suggest for industrial decision-makers
The Scoreboard provides context, not a direct guide to capital allocation. Its company-level figures can nevertheless support more disciplined technology and market assessments:
- Track sector-specific signals. Global growth in ICT and health, alongside continued automotive investment, points to areas worth monitoring when assessing technology developments relevant to industrial operations.
- Separate scale from intensity. Compare R&D investment with sales and sector peers, rather than relying only on absolute spending or regional averages.
- Account for corporate structure. Acquisitions affected reported R&D growth in some cases. Changes in company boundaries can influence year-to-year comparisons, so growth figures do not necessarily represent only internally generated research.
- Read rankings with coverage limits in mind. The Scoreboard depends on R&D disclosure in company accounts, and national accounting and disclosure practices differ. Some countries may therefore be under-represented.
The report also used patent data to compare where inventions were made with where patents were owned. It found that these locations can differ, with foreign companies owning a substantial share of patents in some countries. For decision-makers reviewing innovation ecosystems, this is a reminder that the location of an inventor does not always identify the company that controls the resulting intellectual property.
Conclusion: use R&D data as strategic context
The 2018 Scoreboard depicts a global R&D landscape dominated by a relatively small number of companies, with distinct regional strengths and meaningful differences between sectors. ICT led worldwide growth, while the EU maintained a strong automotive profile and the US retained higher average R&D intensity, particularly in ICT and health.
Industrial organizations can use these patterns to frame questions about technology priorities, competitive positioning and the evolution of supplier and customer industries. The figures are not a substitute for company-level due diligence or sector-specific analysis. Used with those limitations understood, they offer a valuable baseline for interpreting shifts in corporate innovation and industrial investment.